{"aaData": [["1", "AD", "
\nCode indicating optimal treatment of the patient's condition requiring the\naddition of a new drug to the existing drug therapy.\n\n
\nIndicates that drug combinations in which the net pharmacologic response may be\ndifferent from the result expected when each drug is given separately.\n\n
\neRx drug interacts with [DRUG_NAME]. Please advise: To fill this medication,\nsend denial with note stating pt requires both medications or note that\n[DRUG_NAME] should be canceled. If med should not be filled, Cancel RX and send\nreplacement.\n\n
\nCode indicating the evaluation of established therapy for the purpose of\ndetermining whether an existing therapeutic plan should be altered.\n\n
\nA substance having definite shape and volume manufactured for the administration\nof active and/or inert ingredient(s). Solids include tablets, capsules, powders,\ngranules and certain suppositories.\n\n
\nA film that will dissolve in a liquid solvent to form a solution.\n\n
\nA tablet that will dissolve in a liquid solvent to form a solution.\n\n
\nA clear, homogeneous liquid composed of one or more chemical substances\ndissolved in a solvent or mixture of mutually miscible solvents.\n\n
\nA solution intended for reconstitution before administration.\n\n
\nA solution composed of an iced saline slurry with or without active and/or inert\ningredient(s) intended to induce regional hypothermia from the point of\nadministration.\n\n
\nA solid composed of a porous, interlacing, absorbent, usually shape retaining\nmaterial, such as cellulose wood fibers or plastic polymer form.\n\n
\nA solution or suspension composed of active and/or inert ingredient(s) in oil or\nwater, typically dispensed from an atomizer or nebulizer.\n\n
\nA spray composed of a suspension that contains active and/or inert\ningredient(s).\n\n
\nA capsule composed active and/or inert ingredient(s) of as small pellet-like\ngranules. The capsule is intended to be broken open, facilitating the scattering\nof the granules into soft foods, although it may also be swallowed whole.\n\n
\nCode indicating patient communication related to collection of information or\nclarification of a specific limited problem.\n\n
\nA solid composed active and/or inert ingredient(s) in a long, slender\ncylindrical shape.\n\n
\nA solid composed of active and/or inert ingredient(s) in a long narrow piece of\nmaterial.\n\n
\nA tablet intended for administration under the tongue.\n\n
\nA tablet covered with sugar.\n\n
\nA solid or semi-solid composed of active and/or inert ingredient(s) in a wax,\nfat or a glycerin gelatin jelly and that is conical or oval in shape. It is\nintended to be inserted into a body orifice.\n\n
\nInsoluble solid particles composed of active and/or inert ingredient(s) that are\ndispersed in a liquid.\n\n
\nA suspension designed to release active and/or inert ingredient(s) slowly so as\nto achieve a constant circulating concentration of the ingredient over a 12 hour\ntime interval.\n\n
\nA suspension mixed with a liquid to form a solution or suspension before\nadministration.\n\n
\nA dosage form designed to release active and/or inert ingredient(s) slowly so as\nto achieve a constant circulating concentration of the ingredient over a period\nof time.\n\n
\nA tablet intended for administration between the cheek and gum of the oral\ncavity. The active and/or inert ingredient(s) are usually absorbed through the\noral mucosa and designed to be released slowly over a period of time.\n\n
\nCode indicating that the pharmacist performed a clinical laboratory test on a\npatient.\n\n
\nA capsule designed to release active and/or inert ingredient(s) slowly so as to\nachieve a constant circulating concentration of the ingredient over a period of\ntime.\n\n
\nA solution or suspension intended for oral administration and designed to\nrelease active and/or inert ingredient(s) slowly so as to achieve a constant\ncirculating concentration of the ingredient over a period of time.\n\n
\nAn injectable solution or suspension designed to release active and/or inert\ningredient(s) slowly so as to achieve a constant circulating concentration of\nthe ingredient over a period of time.\n\n
\nA capsule composed of active and/or inert ingredient(s) small, spherical\nstructures that contain active and/or inert ingredient(s) encased within a\nshell. It is designed to release ingredients slowly so as to achieve a constant\ncirculating concentration of the ingredient over a period of time.\n\n
\nA tablet designed to release active and/or inert ingredient(s) slowly so as to\nachieve a constant circulating concentration of the ingredient over a period of\ntime.\n\n
\nA solid composed of fibrous strands of material that are used to bind wound\nedges together.\n\n
\nA solid composed of a small piece of absorbent material attached to one end of a\nsmall stick.\n\n
\nA solution or suspension composed of a viscid vehicle that contains a high\nconcentration of sucrose or other sugars and active and/or inert ingredient(s).\n\n
\nA solid composed of a mixture of that active and/or inert ingredient(s) are\npressed or compacted together, usually in the form of a relatively flat and\nround, square or oval shape.\n\n
\nA tablet designed to release active and/or inert ingredient(s) slowly so as to\nachieve a constant circulating concentration of the ingredient over a 12 hour\ntime interval.\n\n
\nCode indicating communication related to collection of information or\nclarification of a specific limited problem.\n\n
\nA tablet designed to release active and/or inert ingredient(s) slowly so as to\nachieve a constant circulating concentration of the ingredient over a 24 hour\ntime interval.\n\n
\nA tablet composed of a conglomerate of particles that contains active and/or\ninert ingredient(s) that have been individually covered with a coating.\n\n
\nA tablet that changes into a solution when added to a liquid solvent.\n\n
\nA tablet that changes into a suspension when added to a liquid solution.\n\n
\nA tablet composed of small fragments of singular, repeating units of that are\nsystematically arranged over an evenly spaced lattice.\n\n
\nA compressed cylindrical tablet composed of medicated powder and dispersed with\na mixture of lactose, powdered sucrose and a moistening agent.\n\n
\nA solid composed of a plug made from absorbent material.\n\n
\nA solid composed of narrow woven fabric or a narrow extruded synthetic material,\nusually with an adhesive on one or both sides.\n\n
\nA semi-solid that is oily and viscous and composed of a hydrocarbon based resin\nformed from the breakdown and distillation of organic substances.\n\n
\nA spray intended for administration to the mucosa of the throat.\n\n
\nCode indicating that the pharmacist recommends the performance of a clinical\nlaboratory test on a patient.\n\n
\nA solution composed of an alcoholic extract or solution of nonvolatile active\nand/or inert ingredient(s).\n\n
\nA paste intended for administration to the teeth.\n\n
\nA substance intended for administration to a body surface.\n\n
\nA cream intended for administration to a body surface.\n\n
\nA foam intended for administration to a body surface.\n\n
\nA gel intended for administration to a body surface.\n\n
\nA lotion intended for administration to a body surface.\n\n
\nA oil intended for administration to a body surface.\n\n
\nA ointment intended for administration to a body surface.\n\n
\nA powder intended for administration to a body surface.\n\n
\nCode indicating activities performed by a pharmacist on behalf of a patient\nintended to allow the patient to function more effectively on his or her own\nbehalf in health promotion and disease prevention, detection, or treatment.\n\n
\nA powder spray intended for administration to the skin.\n\n
\nA solution intended for administration to a body surface.\n\n
\nA spray intended for topical administration.\n\n
\nA suspension intended for administration to a body surface.\n\n
\nA solid discoid composed of active and/or inert ingredient(s) in a suitably\nflavored base, that dissolves when sucked in the mouth.\n\n
\nAn indication that the dosage form has yet to be assigned.\n\n
\nA solid composed of a porous, interlacing, absorbent, usually shape retaining\nmaterial that does not contain active ingredient(s).\n\n
\nA substance intended for administration into the urethra.\n\n
\nA gel intended for administration into the urethra.\n\n
\nA suppository intended for administration within the urethra.\n\n
\nCode indicating that the pharmacist searches or reviews the pharmaceutical and/or\nmedical literature for information related to the care of a patient.\n\n
\nA substance intended for administration in or around the vagina.\n\n
\nA cream intended for administration in or around the vagina.\n\n
\nA dome-shaped insert with a springy, flexible rim intended to be inserted into\nthe vagina and positioned behind the pelvic bone to completely cover the cervix.\n\n
\nA foam composed of active and/or inert ingredient(s), intended for\nadministration in or around the vagina.\n\n
\nA gel composed of active and/or inert ingredient(s), intended for administration\nin or around the vagina.\n\n
\nAn ointment intended for administration in or around the vagina.\n\n
\nA powder composed of active and/or inert ingredient(s), intended for\nadministration in or around the vagina.\n\n
\nA ring composed of active and/or inert ingredient(s), intended for\nadministration in or around the vagina.\n\n
\nA spray composed of active and/or inert ingredient(s), intended for\nadministration in or around the vagina.\n\n
\nA suppository intended for administration within the vagina.\n\n
\nCode indicating communication by a pharmacist to a processor or payer related to\nthe care of the patient.\n\n
\nA tablet intended for vaginal administration.\n\n
\nA solid composed of a thin slice of material that contain active and/or inert\ningredient(s).\n\n
\nA solution or suspension composed of active and/or inert ingredient(s) and\nintended for administration as an irrigant and cleanser.\n\n
\nA semi-solid composed of lipids made up of hydrocarbons or esters of fatty\nacids; active and/or inert ingredient(s) are commonly suspended within the wax\nmatrix layer.\n\n
\nA relatively long and often cylindrical solid composed of active and/or inert\ningredient(s) intended for wound application.\n\n
\nA unit of radioactivity defined as 3.7E-8 atomic disintegrations or other\nnuclear transformations per second or one quintillionth of curie (10E-18 curie).\n\n
\nA SI derived unit of activity of a radionuclide, equal to one nuclear\ndisintegration or other nuclear transition from a particular energy state\noccurring in an amount of a radionuclide during one second-long time interval.\n\n
\nA unit of radioactivity defined as 3.7 E8 atomic disintegrations or other\nnuclear transformations per second. One centicurie is equal to 0.37\ngigabecquerel.\n\n
\nA unit of radioactivity in the CGS system, defined as 3.7 E10 atomic\ndisintegrations or other nuclear transformations per second. One curie is equal\nto 37 gigabecquerels.\n\n
\nA unit of radioactivity defined as 3.7 E9 atomic disintegrations or other\nnuclear transformations per second. One decicurie is equal to 3.7\ngigabecquerels.\n\n
\nCode indicating that the selection of a therapeutically equivalent product to\nthat specified by the prescriber for the purpose of achieving cost savings for\nthe payer.\n\n
\nA unit of radioactivity defined as 3.7E-5 atomic disintegrations or other\nnuclear transformations per second or one quadrillionth of curie (10E-15 curie).\n\n
\nA unit of radioactivity equal to 10E9 nuclear disintegrations or other nuclear\ntransformations per second, or to 10E9 becquerels.\n\n
\nThe unitage assigned by the WHO to International Biological Standards -\nsubstances, classed as biological according to the criteria provided by WHO\nExpert Committee on Biological Standardization (e.g. hormones, enzymes, and\nvaccines), to enable the results of biological and immunological assay\nprocedures to be expressed in the same way throughout the world. The definition\nof an international unit is generally arbitrary and technical, and has to be\nofficially approved by the International Conference for Unification of Formulae.\n\n
\nA unit of radioactivity equal to 10E3 nuclear disintegrations or other nuclear\ntransformations per second, or to 10E3 becquerels.\n\n
\nA unit of radioactivity equal to 10E6 nuclear disintegrations or other nuclear\ntransformations per second, or to 10E6 becquerels.\n\n
\nA SI derived unit of mass concentration defined as the concentration of one\nkilogram of a substance per unit volume of the mixture equal to one cubic meter,\nor the concentration of one milligram of a substance per unit volume of the\nmixture equal to one milliliter, or one gram of a substance per one liter of the\nmixture. It is also a unit of mass density (volumic mass) defined as the density\nof substance which mass equal to one milligram occupies the volume one\nmilliliter.\n\n
\nA unit of radioactivity equal to one millionth of a curie or 37 kilobecquerels,\nand corresponding to a radioactivity of 37 000 atomic disintegrations per\nsecond.\n\n
\nA unit of mass flow rate equivalent to the rate at which one millionth of a gram\nof matter crosses a given surface or is delivered to a given object or space\nover a period of time equal to twenty four hours. Microgram per 24 hours is also\na dose administration rate unit equal to the rate at which one millionth of a\ngram of a product is administered per unit of time equal to twenty four hours.\n\n
\nThe quantity of micrograms in a volume of fifteen milliliters of a substance.\n\n
\nA unit of mass flow rate equivalent to the rate at which one millionth of a gram\nof matter crosses a given surface or is delivered to a given object or space\nover a period of time equal to one hour.\n\n
\nWhen ZZ is used, the textual DUE Acknowledgment Reason must be used to provide\nadditional detail.\n\n
\nA metric unit of mass concentration defined as the concentration of one gram of\na substance per unit volume of the mixture equal to one cubic meter. The concept\nalso refers to the metric unit of mass density (volumic mass) defined as the\ndensity of a substance which mass equal to one gram occupies the volume of one\ncubic meter.\n\n
\nThe quantity of micrograms prescribed or delivered in three days.\n\n
\nA unit of radioactivity equal to one thousandth of a curie or 37 megabecquerels,\nand corresponding to a radioactivity of 37 millions of atomic disintegrations\nper second.\n\n
\nThe quantity of milligrams in a volume of five milliliters of a substance.\n\n
\nA unit of amount of substance equal to 0.001 mole.\n\n
\nA quantity equivalent to one million units (10E6 units).\n\n
\nA unit of radioactivity equal to one billionth of a curie or 37 becquerels, and\ncorresponding to radioactivity of 37 atomic disintegrations per second.\n\n
\nA unit of radioactivity defined as 0.037 atomic disintegrations or other nuclear\ntransformations per second or one trillionth of curie (10E-12 curie). One\npicocurie is equal to 37 millibecquerels.\n\n
\nA unit of radioactivity defined as 3.7E-14 atomic disintegrations or other\nnuclear transformations per second or one septillionth of curie (10E-24 curie).\n\n
\nA unit of radioactivity defined as 3.7E-11 atomic disintegrations or other\nnuclear transformations per second or one sextillionth of curie (10E-21 curie).\n\n
\nIndicates interactions between a drug and certain foods.\n\n
\nCode indicating that dosage has been evaluated with respect to risk for the\npatient.\n\n
\nQuantity to be based on established dispensing protocols between the prescriber\nand pharmacy/pharmacist.\n\n
\nPart of the Original Medicare Plan managed by the federal government. Covers\nsome, but not all, of the expenses incurred for inpatient hospital care or\nmedical care that a person may receive at a skilled nursing facility (not a\ncustodial care facility). Some hospice care and some home health care are also\ncovered. Limitations apply, and have deductibles, copays, or other costs to\nsatisfy.\n\n
\nPart of the Original Medicare Plan managed by the federal government. This\ncovers medically necessary services from doctors or outpatient hospital care. It\nalso helps with costs associated with some physical and occupational therapist\nservices and some home health care services. A person typically must sign up for\nPart B and pay a monthly premium in order to benefit from coverage.\n\n
\nPart of Medicare includes medical and other benefits provided through private\nhealth benefits companies (approved by the federal government) known as Medicare\nAdvantage Plans. Plans cover the same or better benefits as the Original\nMedicare Plan with easy-to-budget copay and coinsurance amounts when a person\nuses a network doctor and hospital.\n\n
\nCode indicating that activities including interventions with prescribers and\npatients related to the enforcement of a pharmacy benefit plan formulary have\noccurred. Comment: Use this code for cross-licensed brand products or generic to\nbrand interchange.\n\n
\nThe optional Medicare prescription drug coverage.\n\n
\nA program, financed jointly by the federal government and the states, that\nprovides health coverage for mostly low-income women and children as well as\nnursing-home care for low-income elderly.\n\n
\nManaged Medicaid or other managed plans.\n\n
\nA Hospice Organization is responsible for the patient's treatment and\nprescription coverage.\n\n
\nA prescription health insurance program provided by a for-profit, private\ninsurance agency or company.\n\n
\nThe patient (resident or financial guarantor) pays the full cost.\n\n
\nPlan providing workers compensation insurance (insurance required by law from\nemployers for the protection of employees while engaged in the employer's\nbusiness).\n\n
\nA program that offers savings on prescription drugs to patients who are without\nhealth insurance, a traditional benefits plan, or have prescriptions that are\nnot covered by insurance.\n\n
\nReimbursement based on the coupon amount determined by the processor.\n\n
\nA form authorizing a disbursement of cash or a credit against a purchase or\nexpense.\n\n
\nA government-run military veteran benefit system that administers programs of\nveterans' benefits for veterans, their families, and survivors.\n\n
\nAny other payer types not covered by definitions above. New codes, definitions\nand descriptions should be developed for anything classified as Other.\n\n
\nPayer type unknown.\n\n
\nNational Drug Code is a unique 10-digit, 3-segment number. For consistency in\nbilling and reimbursement in the pharmacy services sector of healthcare, the NDC\nin a unique 11-digit formatted number, a zero is added. This number identifies\nthe labeler/manufacturer, product, and package size of the drug. The first\nsegment is the labeler code and assigned by the FDA. The second segment, the\nproduct code, identifies a specific strength, dosage form, and formulation. The\nthird segment, the package code, identifies package sizes. Both the product and\npackage codes are assigned by the labeler/manufacturer.\n\n
\nAn 11 digit code which identifies the manufacturer and the specific description\nof the product.\n\n
\nNational Drug File Reference Terminology - A value descending from the NDF-RT\nconcept types of "Mechanism of Action - N0000000223", "Physiologic Effect -\nN0000009802" or "Chemical Structure - N0000000002". Maintained by VA,\ndistributed by NCI - for classes of medications.\n\n
\nHealth Related Item is a unique 10 digit numeric code assigned to health related\ndrug products by the FDA and the manufacturer or distributor. The format of an\nHRI is 4-6 and it is converted to the 11 digit number used on billing\ntransactions by adding a zero to the 11th position.\n\n
\nThe UNII is a part of the joint USP/FDA Substance Registration System (SRS),\nwhich has been designed to support health information technology initiatives by\nproviding unique identifiers for substances in drugs, biologics, foods, and\ndevices based on molecular structure and/or descriptive information. The SRS is\nused to generate permanent, unique, unambiguous identifiers for substances in\nregulated products, such as ingredients in drug products.\n\n
\nAn RxNorm code maintained and distributed by the National Library of Medicine\n(NLM) representing the ingredient plus strength and dose form.\n\n
\nAn RxNorm code maintained and distributed by the National Library of Medicine\n(NLM) representing the ingredient, strength and dose form plus the branded name.\n\n
\nAn RxNorm code maintained and distributed by the National Library of Medicine\n(NLM) representing the generic drug delivery device.\n\n
\nAn RxNorm code maintained and distributed by the National Library of Medicine\n(NLM) representing the branded drug delivery device.\n\n
\nThe Marketed Product Identifier represents a unique, permanent database object\nthat represents a product name, strength, dosage form, and marketer for brand\nproducts and a name, strength, and dosage form for a generic product.\n\n
\nThe Product Identifier (ProdID) is a permanent database object that represents a\ndrug concept sharing the same active ingredients, dosage form, and strength.\n\n
\nThe Specific Product is a permanent database object that represents a group of\nproducts sharing the same active ingredients, dosage form, and strength.\n\n
\nMandatory, fixed portion of a Unique Device Identifier (UDI) that identifies the\nspecific version or model of a device and the labeler of that device. The DI\nportion is issued by Federal Drug Administration (FDA) Accredited Issuing\nAgencies such as GS1 and HIBCC.\n\n
\nUsed only if Route of Administration is not specified as gastric tube.\n\n
\nAllergy to inactive ingredient found in commercially available product.\n\n
\nDosage form not commercially available.\n\n
\nStrength not commercially available.\n\n
\nPrescriber allows pharmacy to dispense in quantities less than the prescribed\nquantity.\n\n
\nMandatory, fixed portion of a Unique Device Identifier (UDI) that identifies the\nspecific version or model of a device and the labeler of that device. The DI\nportion is issued by Federal Drug Administration (FDA) Accredited Issuing\nAgencies such as GS1 and HIBCC.\n\n
\nDiagnostic criteria for the most common mental disorders including: description,\ndiagnosis, treatment, and research findings. Comments: The Diagnostic and\nStatistical Manual of Mental Disorders - Fifth Edition (DSM-5) is published by\nthe American Psychiatric Association, Washington D.C.\nhttps://www.psychiatry.org/.\n\n
\nDependent between the ages of 0 and 19; age qualifications may vary depending on\npolicy\n\n
\nDependents between the ages of 19 and 25 not attending school; age\nqualifications may vary depending on policy\n\n
\nDependent between the ages of 19 and 25 attending school; age qualifications may\nvary depending on policy\n\n
\nThe residence or legal custody of the student is with both parents\n\n
\nA person who has been judged by a court of competent jurisdiction to be allowed\nto act in his or her own interest; no adult is legally responsible for this\nminor; this may be declared as a result of marriage\n\n
\nRelative related by blood or marriage who resides in the home and is dependent\non the insured for a major portion of their support\n\n
\nIndividual receiving medical service in order to donate organs for a transplant\n\n
\nDeceased individual donating body to be used for research or transplants\n\n
\nChild is covered by the insured but the insured is not the legal guardian\n\n
\nThe state affiliated insurance organization providing coverage and or benefits\nto the claimant\n\n
\nIndicates physical and chemical incompatibilities between two or more drugs.\n\n
\neRx drug is incompatible with [DRUG_NAME]. To fill this Rx, send denial with\nnote stating pt requires both medications or note that [DRUG_NAME] should be\ncanceled. If med should not be filled, Cancel RX and send a replacement.\n\n
\nIndicates that laboratory values may be altered due to the use of the drug, or\nthat the patient's response to the drug may be altered due to a condition that is\nidentified by a certain laboratory value.\n\n
\nThe Marketed Product Identifier represents a unique, permanent database object\nthat represents a product name, strength, dosage form, and marketer for brand\nproducts and a name, strength, and dosage form for a generic product.\n\n
\nThe Product Identifier (ProdID) is a permanent database object that represents a\ndrug concept sharing the same active ingredients, dosage form, and strength.\n\n
\nThe Specific Product is a permanent database object that represents a group of\nproducts sharing the same active ingredients, dosage form, and strength.\n\n
\nNational Drug Code is a unique 10-digit, 3-segment number. For consistency in\nbilling and reimbursement in the pharmacy services sector of healthcare, the NDC\nin a unique 11-digit formatted number, a zero is added. This number identifies\nthe labeler/manufacturer, product, and package size of the drug.\n\n
\nAn 11 digit code which identifies the manufacturer and the specific description\nof the product.\n\n
\nNational Drug File Reference Terminology - A value descending from the NDF-RT\nconcept types of "Mechanism of Action - N0000000223", "Physiologic Effect -\nN0000009802" or "Chemical Structure - N0000000002". Maintained by VA,\ndistributed by NCI - for classes of medications.\n\n
\nHealth Related Item is a unique 10 digit numeric code assigned to health related\ndrug products by the FDA and the manufacturer or distributor. The format of an\nHRI is 4-6 and it is converted to the 11 digit number used on billing\ntransactions by adding a zero to the 11th position.\n\n
\nThe UNII is a part of the joint USP/FDA Substance Registration System (SRS),\nwhich has been designed to support health information technology initiatives by\nproviding unique identifiers for substances in drugs, biologics, foods, and\ndevices based on molecular structure and/or descriptive information.\n\n
\nAn RxNorm code maintained and distributed by the National Library of Medicine\n(NLM) representing the ingredient plus strength and dose form.\n\n
\nAn RxNorm code maintained and distributed by the National Library of Medicine\n(NLM) representing the ingredient, strength and dose form plus the branded name.\n\n
\nAn RxNorm code maintained and distributed by the National Library of Medicine\n(NLM) representing the generic drug delivery device.\n\n
\nAn RxNorm code maintained and distributed by the National Library of Medicine\n(NLM) representing the branded drug delivery device.\n\n
\nThe Marketed Product Identifier represents a unique, permanent database object\nthat represents a product name, strength, dosage form, and marketer for brand\nproducts and a name, strength, and dosage form for a generic product.\n\n
\nThe Product Identifier (ProdID) is a permanent database object that represents a\ndrug concept sharing the same active ingredients, dosage form, and strength.\n\n
\nThe Specific Product is a permanent database object that represents a group of\nproducts sharing the same active ingredients, dosage form, and strength.\n\n
\nMandatory, fixed portion of a Unique Device Identifier (UDI) that identifies the\nspecific version or model of a device and the labeler of that device. The DI\nportion is issued by Federal Drug Administration (FDA) Accredited Issuing\nAgencies such as GS1 and HIBCC.\n\n
\nNational Drug Code is a unique 10-digit, 3-segment number. For consistency in\nbilling and reimbursement in the pharmacy services sector of healthcare, the NDC\nin a unique 11-digit formatted number, a zero is added. This number identifies\nthe labeler/manufacturer, product, and package size of the drug. The first\nsegment is the labeler code and assigned by the FDA\n\n
\nAn 11 digit code which identifies the manufacturer and the specific description\nof the product\n\n
\nNational Drug File Reference Terminology - A value descending from the NDF-RT\nconcept types of "Mechanism of Action - N0000000223", "Physiologic Effect -\nN0000009802" or "Chemical Structure - N0000000002". Maintained by VA,\ndistributed by NCI - for classes of medications.\n\n
\nHealth Related Item is a unique 10 digit numeric code assigned to health related\ndrug products by the FDA and the manufacturer or distributor. The format of an\nHRI is 4-6 and it is converted to the 11 digit number used on billing\ntransactions by adding a zero to the 11th position.\n\n
\nThe UNII is a part of the joint USP/FDA Substance Registration System (SRS),\nwhich has been designed to support health information technology initiatives by\nproviding unique identifiers for substances in drugs, biologics, foods, and\ndevices based on molecular structure and/or descriptive information. The SRS is\nused to generate permanent, unique, unambiguous identifiers for substances in\nregulated products, such as ingredients in drug products.\n\n
\nThe Marketed Product Identifier represents a unique, permanent database object\nthat represents a product name, strength, dosage form, and marketer for brand\nproducts and a name, strength, and dosage form for a generic product.\n\n
\nPreferred means available on a pharmaceutical formulary in a manner such that the\nproduct is given preference in dispensing decisions over competing products in a\ntherapeutic class or therapeutic use.\n\n
\nThe Product Identifier (ProdID) is a permanent database object that represents a\ndrug concept sharing the same active ingredients, dosage form, and strength.\n\n
\nThe Specific Product is a permanent database object that represents a group of\nproducts sharing the same active ingredients, dosage form, and strength.\n\n
\nMandatory, fixed portion of a Unique Device Identifier (UDI) that identifies the\nspecific version or model of a device and the labeler of that device. The DI\nportion is issued by Federal Drug Administration (FDA) Accredited Issuing\nAgencies such as GS1 and HIBCC\n\n
\nThe product is included in the plan formulary.\n\n
\nMay be used to request a prescriber authorize a change to the patient's\ncurrent medication therapy, such as a dosing regimen or an alternative\nmedication that will have fewer, or no, adverse effects than the original\nprescription.\n\n
\nMay be used to request a prescriber allow the dispensing of a generic\nmedication when substitution is not allowed by the prescriber or\nregulations.\n\n
\nRx received was marked Dispense as Written however Brand Name product is not\navailable to be dispensed. Please approve generic substitution option below or\nsend replacement Rx.\n\n
\nMay be used to request a prescriber authorize a change to the original\nprescription due to the pharmacy being out of stock of the requested\nmedication.\n\n
\nThe medication prescribed is currently out of stock. Please submit\na new Rx from the option(s) below.\nVA Formulary: https://www.domain.ext/formularyadvisor/\n\n
\nMay be used to request a prescriber review the drug requested and obtain a\nprior authorization from the payer for the existing prescription.\n\n
\nThis product requires a prior authorization. Please call the VA Pharmacy\nat [PHONE_NUMBER] to discuss.\nVA Formulary: https://www.domain.ext/formularyadvisor/\n\n
\nMay be used to request a prescriber clarify the original prescription.\n\n
\nThe eRx is missing or unclear on [ADD_TEXT_HERE], Please edit and respond or\ncancel Rx and send a new prescription with the requested information.\n\n
\nThe product is not included in the plan formulary.\n\n
\nMay be used to request a prescriber authorize a therapy change to the\nprescription. This includes the workflow where a pharmacy requests a\n30-90 day quantity or a formulary change.\n\n
\nPharmacy is unable to supply medication as prescribed; however, alternative\noptions may exist. Please approve an option below or Cancel Rx and send a\nreplacement.\n\n
\nMay be used to request a prescriber authorization information, such as\nconfirming their DEA number or enrollment with the prescription benefit\nplan. Denied and Validated are the only acceptable RxChangeResponse types\nfor this workflow. Use the elements in the Validated response type to return\nthe requested information.\n\n
\nExpired or no authorization on file with VA. Fax RFS Form (VA 10-10172) to\n[ADD_TEXT_HERE] to request auth, or send Rx to non-VA pharmacy (not covered\nby VA). Rx will be cancelled at this time, resend upon approval including\nauthorization #.\n\n
\nThe product is not reimbursable in the plan formulary.\n\n
\nThe product may be subject to potentially higher copay.\n\n
\nThe coverage status code is not discernible.\n\n
\nCode indicating a pattern of drug use by a patient in a manner that is\nsignificantly different than that prescribed by the prescriber.\n\n
\nThe plan formulary requires that medication in a specific drug class be tried\nprior to the requested medication.\n\n
\nThis indicates the prescription has been signed according to the DEA requirements\nfor electronic prescribing of controlled substances.\n\n
\nCompound as per Change Healthcare\n\n
\nSupplies as per Change Healthcare\n\n
\nUniversal Product Code (UPC)\n\n
\nHealth Related Item (HRI)\n\n
\nNational Drug Code (NDC)\n\n
\nHealth Industry Business Communications Council (HIBCC)\n\n
\nDrug Use Review/Professional Pharmacy Service (DUR/PPS)\n\n
\nCommon Procedure Terminology (CPT4)\n\n
\nCode indicating that the prescription does not follow recommended medication\ndosage.\n\n
\nThe prescribed dosage does not align with manufacturer recommendations. Please\nadvise: To fill as is, send denial to this request with note stating reason fill\nis acceptable. To fill within manufacturer guidelines, approve recommendation\nbelow.\n\n
\nCommon Procidure Terminology (CPT5)\n\n
\nHealth Care Financing Administration Common Procedural Coding System (HCPCS)\n\n
\nPharmacy Practice Activity Classification (PPAC)\n\n
\nNational Pharmaceutical Product Interface Code (NAPPI)\n\n
\nGlobal Trade Identification Number (GTIN)\n\n
\nMedi-span Product Line Generic Product Identifier (GPI)\n\n
\nFirst DataBank Formulation ID (GCN)\n\n
\nIndicates that the prescription received is missing dose and/or frequency\nguidelines.\n\n
\nVA policy prohibits filling prescriptions with only "AS NEEDED" for\ndirections. Please indicate frequency of administration.\n\n
\nIndicates that the prescription received is missing dose and/or frequency\nguidelines.\n\n
\nVA policy prohibits filling prescriptions with only "AS DIRECTED"\ndirections. Please indicate frequency of administration.\n\n
\nMicromedex/Medical Economics Generic Formulation Code (GFC)\n\n
\nIndicates that the prescription received has conflicting directions.\n\n
\nThis prescription contains conflicting directions. Please verify which\ndirections are to be followed.\n\n
\nIndicates that the prescription received has incomplete directions for use.\n\n
\nPlease provide the complete set of patient instructions.\n\n
\nIndicates that the prescription received is missing the route of injection\nfor medication.\n\n
\nPlease verify the ROUTE of injection.\n\n
\nIndicates that the prescription received is missing the formulation of\nmedication to dispense.\n\n
\nPlease verify which formulation should be dispensed.\n\n
\nIndicates the prescription received has a written quantity that is less\nthan typical prescribing.\n\n
\nThe quantity written is less than typically prescribed. Please verify the\nquantity to dispense.\n\n
\nIndicates the prescription received has a written quantity that is less\nthan smallest available quantity to dispense from the pharmacy.\n\n
\nPlease verify the quantity to dispense. Our filling sites are only able to\nprovide this product in quantities of [QUANTITY], which is more than the\ntotal quantity prescribed.\n\n
\nIndicates the Prescriber is not authorized by VA to see this patient.\n\n
\nVA records show this patient does not have active authorization for care\nfrom your office. This prescription will be removed from the VA system.\nFor authorization questions, patients or providers can call the VA Office\nof Community Care at [PHONE_NUMBER].\n\n
\nIndicates a change in the days supply for the medication prescribed.\n\n
\nPharmacy would like to dispense this medication for 90 days of supply\ninstead 30 days. Please approve the 90-days option below or Cancel Rx and\nsend a replacement.\n\n
\nIndicates Pharmacy is unable to supply medication as prescribed.\n\n
\nPharmacy is unable to supply medication as prescribed; however, alternative\noptions may exist. Please approve an option below or Cancel Rx and send a\nreplacement.\n\n
\nMedi-Span Product Line Drug Descriptor ID (DDID)\n\n
\nFirst DataBank SmartKey\n\n
\nCode indicating that a conflict was detected when a prescribed drug is\ncontraindicated or might conflict with the use of tobacco products.\n\n
\nMicromedex/Medical Economics Generic Master (GM)\n\n
\nInternational Classification of Diseases (ICD9)\n\n
\nInternational Classification of Diseases-1-Clinical Modifications (ICD-1-CM)\n\n
\nMedi-Span Product Line Diagnosis Code\n\n
\nNational Criteria Care Institute (NCCI)\n\n
\nThe Systematized Nomenclature of Human and Veterinary Medicine (SNOMED)\n\n
\nCommon Dental Terminology (CDT)\n\n
\nAmerican Psychiatric Association Diagnostic Statistical Manual of Mental\nDisorders (DSM IV)\n\n
\nInternational Classification of Diseases-1-Procedure Coding System (ICD-1-PCS)\n\n
\nFirst DataBank Medication Name ID (FDB Med Name ID)\n\n
\nCode indicating that a cognitive service whereby the pharmacist performed a\npatient care activity by providing additional instructions or education to the\npatient beyond the simple task of explaining the prescriber's instructions on the\nprescription.\n\n
\nFirst DataBank Routed Medication ID (FDB Routed Med ID)\n\n
\nFirst DataBank Routed Dosage Form ID (FDB Routed Dosage Form Med ID)\n\n
\nFirst DataBank Medication ID (FDB MedID)\n\n
\nFirst DataBank Clinical Formulation ID Sequence Number (GCN_SEQ_NO)\n\n
\nFirst DataBank Ingredient List ID (HICL_SEQ_NO)\n\n
\nUniversal Product Number (UPN)\n\n
\nLogical Observation Identifier Names and Codes (LOINC)\n\n
\nRepresentative National Drug Code (NDC)\n\n
\nAmerican Hospital Formulary Service (AHFS)\n\n
\nRxNorm Semantic Clinical Drug (SCD)\n\n
\nCode indicating that the current prescription refill is occurring before the days\nsupply of the previous filling should have been exhausted.\n\n
\nSemantic Branded Drug (SBD)\n\n
\nRxNorm Generic Package (GPCK)\n\n
\nRxNorm Branded Package (BPCK)\n\n
\nOther\n\n
\nCode that documents the quantity is excessive for the single time period for\nwhich the drug is being prescribed.\n\n
\nCode indicating that circumstances required the pharmacist to verify the validity\nand/or authenticity of the prescription.\n\n
\nDetects drug doses that fall above the standard dosing range.\n\n
\nThe prescribed dosage exceeds typical maximum. Please advise: To fill as is,\nsend denial to this request with note stating reason fill is acceptable. To\nfill within manufacturer guidelines, approve recommendation below.\n\n
\nCode indicating that a possible inappropriate use of drugs that are designed to\namerliorate complications caused by another medication has been detected.\n\n
\nCode indicating that simultaneous use of drug products containing one or more\nidentical generic chemical entities has been detected.\n\n
\nPt has medication containing the same ingredient on file. To fill this Rx, send\ndenial with note stating pt requires both medications or note that [DRUG_NAME]\nshould be canceled. If med should not be filled-Cancel RX and send a\nreplacement.\n\n
\nRepresents the product or generic name, route of administration, and dosage\nform.\n\n
\nCode indicating that the submitted drug doses fall below the standard dosing\nrange.\n\n
\nThe prescribed dosage is below typical minimum. Please advise: To fill as is,\nsend denial to this request with note stating reason fill is acceptable. To fill\nwithin manufacturer guidelines, approve recommendation below.\n\n
\nCode indicating that the professional service was related to a plan/payer\nconstraint on the member whereby the member is required to obtain services from\nonly one specified pharmacy or other provider type, hence the member is "locked\nin" to using only those providers or pharmacies.\n\n
\nCode indicating that a prescription refill that occurred after the days supply of\nthe previous filling should have been exhausted.\n\n
\nIndicates that the use of the drug may be inappropriate in light of a specific\nmedical condition that the patient has. Information about the specific medical\ncondition was provided by the prescriber, patient or pharmacist.\n\n
\nCode indicating that regimens shorter than the minimal limit of therapy for the\ndrug product, based on the product's common uses, has been detected.\n\n
\nCode indicating that the prescription order is unclear, incomplete, or illegible\nwith respect to essential information.\n\n
\nThe eRx is missing or unclear on [ADD_TEXT_HERE], Please edit and respond or\ncancel Rx and send a new prescription with the requested information.\n\n
\nDetects regimens that are longer than the maximal limit of therapy for a drug\nproduct based on the product's common uses.\n\n
\nCode indicating an adverse reaction by a patient to a drug.\n\n
\nPatient has an adverse drug reaction to medication/component of medication\nprescribed. To fill as is, send denial to this request with note stating reason\nfill is acceptable. If med should not be filled- Cancel RX and send a\nreplacement.\n\n
\nIndicates the drug is not currently available from any source.\n\n
\nCode indicating a cognitive service whereby a patient is counseled, the\npharmacist's recommendation is accepted and a claim is submitted to the processor\nrequesting payment for the professional pharmacy service only, not the drug.\n\n
\nCode indicating that a professional pharmacy service has been performed for a\npatient who has a newly diagnosed condition or disease.\n\n
\nCode indicating that mandatory formulary enforcement activities have been\nperformed by the pharmacist when the drug is not included on the formulary of the\npatient's pharmacy benefit plan.\n\n
\nCode indicating that the drug is no longer needed by the patient.\n\n
\nCode indicating that a pharmacist has performed the initial interview and\nmedication history of a new patient.\n\n
\nCode indicating that the drug is excreted in breast milk and may represent a\ndanger to a nursing infant.\n\n
\nCode indicating that the quantity of dosage units prescribed is insufficient.\n\n
\nDetects when a prescribed drug is contraindicated or might conflict with the use\nof alcoholic beverages.\n\n
\nIndicates age\n\n
\nCode indicating a detection of drugs with similar side effects when used in\ncombination could exhibit a toxic potential greater than either agent by itself.\n\n
\nCode indicating that a request for information/concern was expressed by the\npatient, with respect to patient care.\n\n
\nIndicates pregnancy related drug problems. This information is intended to assist\nthe healthcare professional in weighing the therapeutic value of a drug against\npossible adverse effects on the fetus.\n\n
\nCode indicating that the provided professional service was to educate the patient\nregarding measures mitigating possible adverse effects or maximizing the benefits\nof the product(s) dispensed; or measures to optimize health status, prevent\nrecurrence or exacerbation of problems.\n\n
\nCode indicating that a prescriber has requested information or a recommendation\nrelated to the care of a patient.\n\n
\nCode indicating that a cognitive service whereby a pharmacist, in consultation\nwith the prescriber or using professional judgment, recommends a course of\ntherapy as outlined in the patient's plan and submits a claim for the\nprofessional service provided.\n\n
\nCode identifying the patient has had a previous atypical reaction to drugs.\n\n
\nCode indicating that an acceptable generic substitute or a therapeutic equivalent\nexists for the drug. This code is intended to support discretionary drug product\nselection activities by pharmacists.\n\n
\nPharmacy is unable to provide this medication. Please approve an option\n below or cancel rx.\nVA Formulary: https://www.domain.ext/formularyadvisor/\n\n
\nCode indicating that the professional service was provided to obtain information\nfrom the patient regarding suspected environmental factors.\n\n
\nPatient referred to the pharmacist by another health care provider for disease\nspecific or general purposes.\n\n
\nCode indicating that professional service was provided to counsel the patient\nregarding the importance of adherence to the provided instructions and of\nconsistent use of the prescribed product including any ill effects anticipated as\na result of non-compliance.\n\n
\nThe patient is participating in a coordinated health care intervention program.\n\n
\nCode indicating incorrect, inappropriate, or less than optimal drug prescribed\nfor the patient's condition.\n\n
\nCode reporting possible major side effects of the prescribed drug.\n\n
\nCode indicating incorrect, inappropriate, or less than optimal dosage form for\nthe drug.\n\n
\nCode indicating incorrect, inappropriate, or less than optimal dosage regimen\nspecified for the drug in question.\n\n
\nIndicates the therapy is inappropriate or contraindicated in either males or\nfemales.\n\n
\nThe prescribed medication does not align with manufacturer recommendations based\non patient sex assigned at birth. The pharmacy is unable to fill the medication\nas prescribed. Pt may obtain locally at usual cash price.\n\n
\nCode indicating that a simultaneous use of different primary generic chemical\nentities that have the same therapeutic effect was detected.\n\n
\nPt has medication of the same class/indication/drug on file. To fill this Rx,\nsend denial with note stating pt requires both medications or note that\n[DRUG_NAME] should be canceled. If this med should not be filled, Cancel RX and\nsend a replacement.\n\n
\nCode indicating that an assessment of the patient suggests that a laboratory test\nis needed to optimally manage a therapy.\n\n
\nQuestion Code indicating that a payer or processor requested information related\nto the care of a patient.\n\n
\nPrior to processing this medication/class the pharmacy is required to obtain a\ndiagnosis code. Please edit and respond or Cancel Rx and send a new prescription\nwith the requested information.\n\n
\nCode indicating that multiple prescriptions of the same drug formulation are\npresent in the patient's current medication profile.\n\n
\nPt has multiple prescriptions for the same drug and strength on file. To fulfill\nboth Rx, send one Rx containing total qty/directions etc. To fill only this Rx,\nsend denial with note stating other should be canceled. If med should not be\nfilled, Cancel Rx.\n\n
\nA category of drugs not considered legitimate for medical use.\n\n
\nA category of drugs considered to have a strong potential for abuse or addiction\nbut that also have legitimate medical use.\n\n
\nProcessor message to recommend the receiver contact the processor/plan.\n\n
\nCognitive service whereby the pharmacist reviews and evaluates a therapeutic\nissue (alert) and determines the alert is incorrect for that prescription for\nthat patient and fills the prescription as originally written.\n\n
\nA category of drugs that have less potential for abuse or addiction than\nSchedule I or II drugs and have a useful medical purpose.\n\n
\nA category of medically useful drugs that have less potential for abuse or\naddiction than those of Schedules I, II, and III.\n\n
\nA category of medically useful drugs that have less potential for abuse or\naddiction than those of Schedules I through IV.\n\n
\nNot stated explicitly or in detail.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in an\nactuation.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in an\nampule.\n\n
\nA dosing measurement based on the application unit.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a single\napplicator.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in an\nauto-injector.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a bar.\n\n
\nCognitive service whereby the pharmacist reviews and evaluates a therapeutic\nissue (alert) and determines the alert is not relevant for that prescription for\nthat patient and fills the prescription as originally written.\n\n
\nA dosing measurement based on the capful unit.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a caplet.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a\ncapsule.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a\ncartridge.\n\n
\nA basic unit of length in the former CGS version of metric system, equal to one\nhundredth of a meter or approximately 0.393 700 787 inch.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a disk.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a\ndropperful.\n\n
\nUsed to refer to every member of a group of people or things, considered\nindividually.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a film.\n\n
\nA traditional unit of liquid volume equal in the US customary system to 1/16\npint, or 1.804 687 cubic inches or 29.573 531 milliliters.\n\n
\nCognitive service whereby the pharmacist reviews and evaluates a therapeutic\nissue (alert) and fills the prescription with a different dose than was\noriginally prescribed.\n\n
\nThe US unit of liquid volume legally defined as 3785.411784 milliliters (3.785\n411 784 liters), or 231 cubic inches. The US gallon holds 4 liquid quarts; the\ngallon of water gallon weighs approximately 8.33 pounds.\n\n
\nThe metric unit of mass equal to one thousandth of a kilogram. One gram equals\napproximately 15.432 grains or 0.035 273 966 ounce.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a gum.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in an\nimplant.\n\n
\nA traditional unit of length equal to 1/12 of a foot or 2.54 centimeters.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in an inch\nribbon of a topical substance.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in an\ninhalation.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in an\ninjection.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in an\ninsert.\n\n
\nThe non-SI unit of volume accepted for use with the SI. One liter is equal to\ncubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or\napproximately 61.023 744 cubic inches.\n\n
\nCognitive service whereby the pharmacist reviews and evaluates a therapeutic\nissue (alert) and fills the prescription with different directions than were\noriginally prescribed.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a\nlollipop.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a\nlozenge.\n\n
\nA unit of volume used in pharmacy and equal to 0.05 milliliter (20 drops/ml).\n\n
\nA metric unit of mass equal to one millionth of a gram or one thousandth of a\nmilligram.\n\n
\nA unit of relative amount of a substance equal to one thousandth of an\nequivalent weight.\n\n
\nA metric unit of mass equal to one thousandth of a gram or 1000 micrograms. One\nmilligram equals approximately 0.015 432 grain or 35.274 x 10E-6 ounce.\n\n
\nA unit of volume equal to one millionth (10E-6) of a cubic meter, one thousandth\nof a liter, one cubic centimeter, or 0.061023 7 cubic inch. A cubic centimeter\nis the CGS unit of volume.\n\n
\nA quantity equivalent to the one thousandth unit (10E-3 unit).\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a nebule.\n\n
\nThe traditional unit of mass. The avoirdupois ounce is equal to 1/16 pound, or\n28.349 5 grams, or 0.911 457 troy ounce.\n\n
\nCognitive service whereby the pharmacist reviews and evaluates a therapeutic\nissue (alert) and fills the prescription with a different drug than was\noriginally prescribed.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a\npackage.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a packet.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a pad.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a patch.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a pellet.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a pill.\n\n
\nA United States liquid unit equal to 16 fluid ounces; two pints equal one quart.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in an\npre-filled pen syringe.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a puff.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in one\nactuation of a pumping device.\n\n
\nCognitive service whereby the pharmacist reviews and evaluates a therapeutic\nissue (alert) and fills the prescription with a different quantity than was\noriginally prescribed.\n\n
\nA United States liquid unit equal to 32 fluid ounces; four quarts equal one\ngallon.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a ring.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a sachet.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained typically in\na spoon-shaped object.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a sponge.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a spray.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a stick.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a strip.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a\nsuppository.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a swab.\n\n
\nCognitive service whereby the pharmacist reviews and evaluates a therapeutic\nissue (alert) and fills the prescription after consulting with or obtaining\napproval from the prescriber.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a single\nsyringe.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a tablet.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a troche.\n\n
\nA single undivided thing occurring in the composition of something else.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a single\nvial.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a wafer.\n\n
\nThe length of a person's life, stated in months since birth.\n\n
\nThe length of a person's life, stated in years since birth.\n\n
\nThe number of heartbeats measured per minute time.\n\n
\nAn individual's weight in kilograms divided by the square of the height in\nmeters.\n\n
\nAction whereby a pharmacist dispenses the generic formulation of an originally\nprescribed branded product. Allowed, often mandated, unless the prescriber\nindicates "Do Not Substitute" on the prescription\n\n
\nA measure of the 2-dimensional extent of the body surface (i.e., the skin). \nBody surface area (BSA) can be calculated by mathematical formula or from a\nchart that relates height to weight. BSA is often an important factor in\ndosing.\n\n
\nThe weight of a subject.\n\n
\nThe number of breaths (inhalation and exhalation) taken per minute time.\n\n
\nThe time for Earth to make a complete rotation on its axis; ordinarily divided\ninto twenty-four hours, equal to 86 400 seconds. This also refers to a specific\nday.\n\n
\nA unit of temperature of the temperature scale designed so that the freezing\npoint of water is 0 degrees and the boiling point is 100 degrees at standard\natmospheric pressure. The current official definition of the Celsius sets 0.01 C\nto be at the triple point of water and a degree to be 1/273.16 of the difference\nin temperature between the triple point of water and absolute zero. One degree\nCelsius represents the same temperature difference as one Kelvin.\n\n
\nA unit of temperature of the temperature scale designed so that the freezing\npoint of water is 32 degrees and the boiling point is 212 degrees, placing the\nboiling and melting points of water 180 degrees apart. One degree Fahrenheit is\n5/9ths of a kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is\nequal to minus 40 degrees Celsius.\n\n
\nThe minimum pressure exerted into the systemic arterial circulation during\ncardiac ventricular relaxation and filling.\n\n
\nThe number of heartbeats per unit of time, usually expressed as beats per\nminute.\n\n
\nThe vertical measurement or distance from the base to the top of an object; the\nvertical dimension of extension.\n\n
\nA basic SI unit of mass. It is defined as the mass of an international prototype\nin the form of a platinum-iridium cylinder kept at Sevres in France. A kilogram\nis equal to 1,000 grams and 2.204 622 6 pounds.\n\n
\nCode indicating a cognitive service. The pharmacist reviews and evaluates a\ntherapeutic issue (alert) fills the prescription with an over-the-counter product\nin lieu of the originally prescribed prescription-only product.\n\n
\nThe mean pressure of the blood within the arterial circulation. The arterial\npressure may be directly measured by insertion of an intra-arterial catheter\nconnected to a transducer. The mean arterial pressure (MAP) can be calculated by\nsubsequent analysis of the waveform. MAP can be approximated without an invasive\nprocedure using the following formula: diastolic pressure plus 1/3 of the pulse\npressure, where pulse pressure is systolic pressure - diastolic pressure.\n\n
\nA non-SI unit of pressure equal to 133,332 Pa or 1.316E10-3 standard atmosphere.\nUse of this unit is generally deprecated by ISO and IUPAC.\n\n
\nOne of the 12 divisions of a year as determined by a calendar. It corresponds to\nthe unit of time of approximately to one cycle of the moon's phases, about 30\ndays or 4 weeks.\n\n
\nA fraction or ratio with 100 understood as the denominator.\n\n
\nThe traditional unit of mass. By international agreement, one avoirdupois pound\nis equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds.\n\n
\nThe rate of the pulse as observed in an artery, expressed as beats per minute.\nIt can be measured at several anatomical sites, including the wrist, neck,\ntemple, groin, behind the knees, or on top of the foot.\n\n
\nThe rate of breathing (inhalation and exhalation) measured within in a unit\ntime, usually expressed as breaths per minute.\n\n
\nA standard measure of visceral obesity, or abdominal fat, which is measured from\nthe patient's back to upper abdomen between the bottom of the rib cage and the\ntop of the pelvic area. This measurement may be taken with the patient standing\nor in the supine position.\n\n
\nA SI unit of area measurement equal to a square whose sides are one meter long.\nSquare meter is equal to 10,000 square centimeters; 0.01 are; 1.196 square\nyards; 10.76 square feet; 1550 square inches.\n\n
\nThe maximum pressure exerted into the systemic arterial circulation during the\ncontraction of the left ventricle of the heart.\n\n
\nCognitive service whereby the pharmacist reviews and evaluates a therapeutic\nissue (alert) and fills the prescription with a different dosage form than was\noriginally prescribed.\n\n
\nA measure of the average kinetic energy of a system of particles. Temperature\nmay be quantified, in the context of thermodynamics, as the potential of one\nsystem to transfer thermal energy to another system until both systems reach a\nstate of thermal equilibrium.\n\n
\nA period of time that it takes for Earth to make a complete revolution around\nthe sun, approximately 365 days; a specific one year period.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a\nblister.\n\n
\nA dosing unit equal to the amount of active ingredient(s) contained in a kit.\n\n
\nA small, sharp, needle-like instrument that is used to puncture the skin.\n\n
\nA single use, hollow needle embedded in a plastic hub, which is then attached to\na preloaded syringe (pen) to facilitate the delivery of medication.\n\n
\nA drug pack that contains a 21 day supply of tablets, composed of a mixture of\nactive and/or inert ingredient(s) that are pressed or compacted into a solid\nround, square or oval shaped form.\n\n
\nA drug pack that contains a 28 day supply of tablets, composed of a mixture of\nactive and/or inert ingredient(s) that are pressed or compacted into a solid\nround, square or oval shaped form.\n\n
\nA syringe with a measured dose of medication that has an apparatus that enables\nthe user to specify the amount of the medication to deliver in an injection.\n\n
\nA suppository intended for administration to adults.\n\n
\nCode indicating that in the course of assessment or discussion with the patient,\nthe pharmacist identified an actual or potential problem when the patient\npresented to the pharmacist complaints or symptoms suggestive of illness\nrequesting evaluation and treatment.\n\n
\nCode indicating a cognitive service. The pharmacist reviews and evaluates a\ntherapeutic issue (alert) and determines that the prescription should not be\nfilled as written.\n\n
\nContents packaged under pressure that are released upon activation of an\nappropriate valve system.\n\n
\nA foam that is packaged under pressure and released upon activation of an\nappropriate valve system.\n\n
\nA mist that is packaged under pressure and released upon activation of an\nappropriate valve system.\n\n
\nA homogenous solution comingled with a propellant and packaged under pressure.\nUpon activation of an appropriate valve system, the liquid is expelled into the\nair, the propellant is vaporized and the ingredients are dispersed.\n\n
\nA spray that is packaged under pressure and released upon activation of an\nappropriate valve system.\n\n
\nA cream that is modified to enhance the release of active and/or inert\ningredient(s).\n\n
\nA gel that is modified to enhance the release of active and/or inert\ningredient(s).\n\n
\nA lotion that is modified to enhance the release of active and/or inert\ningredient(s).\n\n
\nAn ointment that is modified to enhance the release of active and/or inert\ningredient(s).\n\n
\nActive and/or inert ingredient(s) in a device that is automated to deliver a\ndesignated dose.\n\n
\nCognitive service whereby the pharmacist reviews and evaluates a therapeutic\nissue (alert), consults with the prescriber or using professional judgment, does\nnot fill the prescription and counsels the patient as to the prescriber's\ninstructions.\n\n
\nA solid composed of single or multilayered strips of permeable material.\n\n
\nA solid or semi-solid in a singular unit that is rectangular or oval in shape.\n\n
\nA solid in the shape of a bar composed of active and/or inert ingredient(s) in\nan anionic surfactant, for cleansing.\n\n
\nA solid in the shape of a small sphere.\n\n
\nA capsule designed to be bitten to release the active and/or inert\ningredient(s).\n\n
\nA solid or semi-solid in the shape of a square or rectangle.\n\n
\nA capsule intended for administration between the cheek and gum of the oral\ncavity. The active and/or inert ingredient(s) are usually absorbed through the\noral mucosa.\n\n
\nA thin layer of water soluble or insoluble polymer intended to coat the inner\nsurface of the cheek.\n\n
\nA tablet intended for administration between the cheek and gum of the oral\ncavity. The active and/or inert ingredient(s) are usually absorbed through the\noral mucosa.\n\n
\nA solid composed of dry powdered active and/or inert ingredient(s) covered by an\nedible shell. The shell consists of two concave pieces of wafer made of flour\nand water.\n\n
\nCode indicating a cognitive service. The pharmacist reviews and evaluates a\ntherapeutic issue (alert), recommends a more appropriate product or regimen then\ndispenses the alternative after consultation with the prescriber.\n\n
\nA solid composed of active ingredient(s), excipients (usually electrolytes and\nbulking agents), and a solvent system which are lyophilized to yield a\ncompressed solid with uniform ingredient distribution. The resulting lyophilized\ncake maintains its structure and stability over an extended period of time, and\nis intended for reconstitution prior to administration.\n\n
\nA solid or semi-solid with a sweet taste and intended for oral administration.\n\n
\nA solid contained within either a hard or soft soluble shell, usually prepared\nfrom gelatin.\n\n
\nA capsule designed to release active and/or inert ingredient(s) slowly so as to\nachieve a constant circulating concentration of the ingredient over a 12 hour\ntime interval.\n\n
\nA capsule designed to release active and/or inert ingredient(s) slowly so as to\nachieve a constant circulating concentration of the ingredient over a 24 hour\ntime interval.\n\n
\nA base composed of bonding agents intermingled with active and/or inert\ningredient(s), which rapidly hardens into a firm mass upon application.\n\n
\nA bar designed to be chewed to release active and/or inert ingredient(s).\n\n
\nA capsule designed to be chewed to release the active and/or inert\ningredient(s).\n\n
\nA tablet that must be chewed to release the active and/or inert ingredient(s).\n\n
\nA semi-solid composed of synthetic, polymerized polysaccharide and flavorings,\nintended to be chewed to release active and/or inert ingredient(s).\n\n
\nCode indicating a cognitive service. The pharmacist reviews and evaluates a\ntherapeutic issue (alert), recommends a more appropriate product or regimen but\nthe prescriber does not concur.\n\n
\nA solid composed of active and/or inert ingredient(s) wrapped in a paper\ncylinder whereby one end is burned. The ingredient is released in a smoke form,\nwhich is inhaled.\n\n
\nA solid composed active and/or inert ingredient(s) in a woven absorbent\nmaterial.\n\n
\nA capsule that contains an additional outer layer over the capsule shell.\n\n
\nA capsule composed of small globular masses covered with an outer shell.\n\n
\nA tablet whose outer shell is covered with a substance.\n\n
\nA tablet that has been compacted into capsule shape and covered in sugar.\n\n
\nA solution or suspension composed of active and/or inert ingredient(s) with\nincreased strength in a reduced volume, which is usually diluted prior to\nadministration.\n\n
\nA concentrate which is usually diluted prior to administration by injection.\n\n
\nA concentrate that usually requires dilution prior to oral administration.\n\n
\nA concentrate which is usually diluted prior to administration and exists as a\nsolution in its final form.\n\n
\nCognitive service involving the pharmacist's review of drug therapy that results\nin the removal of a medication from the therapeutic regimen.\n\n
\nA solid with a shape bounded by a circular base converging upon a single vertex.\n\n
\nA solid, semi-solid, solution or suspension designed to release active and/or\ninert ingredient(s) at a controlled rate.\n\n
\nA capsule designed to release active and/or inert ingredient(s) at a controlled\nrate.\n\n
\nA solution or suspension designed to release active and/or inert ingredient(s)\nat a controlled rate.\n\n
\nA tablet designed to release active and/or inert ingredient(s) at a controlled\nrate.\n\n
\nA semi-solid composed of an emulsion of lipids, hydrocarbons, waxes, or polyols\nin water.\n\n
\nA solid that consists of naturally produced angular solids composed of singular,\nrepeating units that are systematically arranged in an evenly spaced lattice.\n\n
\nA solid or semi-solid in the shape of a three dimensional square.\n\n
\nA solution, suspension or semi-solid composed of media conducive to microbial\ngrowth.\n\n
\nA capsule designed to dissolve after releasing the active and/or inert\ningredient(s) at a controlled rate.\n\n
\nThe pharmacist reviews and evaluates a therapeutic issue (alert), recommends a\nmore appropriate regimen then dispenses the recommended medication(s) after\nconsultation with the prescriber.\n\n
\nA solid, semi-solid, solution or suspension that has been coated with a\nsubstance that is designed to impede the immediate release of the active and/or\ninert ingredient(s) after administration.\n\n
\nA capsule covered with a substance that is designed to impede the immediate\nrelease of the active and/or inert ingredient(s) after administration.\n\n
\nA solid composed of small particles or grains and have been coated with a\nsubstance that is designed to impede the immediate release of the active and/or\ninert ingredient(s) after administration.\n\n
\nA tablet composed of individual fragments have been coated with a substance that\nis designed to impede the immediate release of the active and/or inert\ningredient(s) after administration.\n\n
\nA capsule composed of active and/or inert ingredient(s) small, spherical\nstructures that have been coated with a substance that is designed to impede the\nimmediate release of the active and/or inert ingredient(s) after administration.\n\n
\nA tablet that has been coated with a substance that is designed to impede the\nimmediate release of the active and/or inert ingredient(s) after administration.\n\n
\nAn substance intended for use on the teeth or gingiva in the oral cavity.\n\n
\nA solid bounded by a circular base converging upon a single vertex and intended\nfor administration to the teeth and gingiva in the oral cavity.\n\n
\nA resinous film-forming agent dissolved in a solvent or a calcium hydroxide\nsuspension within a synthetic resin solution, which rapidly hardens into a firm\nmass upon administration.\n\n
\nA gel intended for use in the oral cavity to clean the teeth and maintain oral\nhygiene.\n\n
\nThe pharmacist reviews and evaluates a therapeutic issue (alert), recommends a\nmore appropriate product or regimen then dispenses the alternative after\nconsultation with the prescriber.\n\n
\nA paste of mild abrasives, detergents, flavoring agents, binders, fluoride, and\nother active and/or inert ingredient(s).\n\n
\nA powder composed of a mild abrasives, detergents, flavoring agents, binders,\nfluoride, and other active and/or inert ingredient(s).\n\n
\nA solid, semi-solid, solution or suspension covered with an outer permeable\npolymeric membrane designed to release active and/or inert ingredient(s) at a\ncontrolled, prolonged rate so as to reduce dosing frequency. Water permeates\nthrough the membrane to the core to dissolve the ingredient(s) which\nsubsequently exit the membrane at a rate determined by their solubility and the\nthickness and porosity of the membrane.\n\n
\nA flat, circular shaped form composed of a solid or powder that contains active\nand/or inert ingredient(s).\n\n
\nA tablet that dissolves or melts quickly (usually within a matter of seconds)\nwhen it comes into contact with a liquid.\n\n
\nA tablet composed of a large amount of active and/or inert ingredient(s) that\ncan be used in compounding prescriptions to ensure accurate quantity of\ningredient within the final, compounded form.\n\n
\nA solid, semi-solid, solution or suspension composed of active and/or inert\ningredient(s) covered with or contained within a polymeric matrix such that\ndissolution is determined by the solubility rate of the given polymer. It is\ndesigned to release ingredients at a controlled, prolonged rate so as to reduce\ndosing frequency.\n\n
\nA substance intended for use as a vaginal irrigant.\n\n
\nA powder which may be mixed with a liquid, intended for administration as a\nvaginal irrigant.\n\n
\nA solution intended for use as a vaginal irrigant.\n\n
\nThe pharmacist reviews and evaluates a therapeutic issue (alert), recommends a\nmore appropriate product or regimen acknowledging that a cost increase will be\nincurred, then dispenses the alternative after consultation with the prescriber.\n\n
\nA substance intended for administration in or on a wound.\n\n
\nA substance intended for administration in a drop-wise fashion.\n\n
\nA solution intended for administration in a drop-wise fashion.\n\n
\nA suspension intended for administration in a drop-wise fashion.\n\n
\nA suspension prepared immediately prior to dispensing or administration in a\ndrop-wise fashion.\n\n
\nA powder intended to be dusted over the outer surface of the body.\n\n
\nA granule composed of active and/or inert ingredient(s), and a mixture of acids\nand sodium bicarbonate, which release carbon dioxide when dissolved in water.\n\n
\nA powder composed of active and/or inert ingredient(s), and a mixture of acids\nand sodium bicarbonate, which release carbon dioxide when dissolved in water.\n\n
\nA tablet composed of active and/or inert ingredient(s), and a mixture of acids\nand sodium bicarbonate, which release carbon dioxide when dissolved in water.\n\n
\nA patch that composed of active and/or inert ingredient(s) whose release is\ncontrolled by electronic impulses that release ingredients at a controlled,\nprolonged rate so as to reduce dosing frequency.\n\n
\nCognitive service whereby the pharmacist reviews and evaluates a therapeutic\nissue (alert), consults with the prescriber or uses professional judgment and\nsubsequently fills the prescription as originally written.\n\n
\nA solution composed of a clear, sweetened hydroalcoholic liquid in which active\nand/or inert ingredient(s) are dissolved.\n\n
\nA semi-solid composed of at least two immiscible liquids, one of which is\ndispersed as droplets within the other liquid, and stabilized with one or more\nemulsifying agents.\n\n
\nAn emulsion intended for injection.\n\n
\nA solution or suspension intended for administration into the rectum.\n\n
\nA powder that is suspended in liquid prior to administration to the rectum.\n\n
\nA tablet that is suspended in liquid prior to administration to the rectum.\n\n
\nA capsule covered with a substance that is designed to delay the release of\nactive and/or inert ingredient(s) until the capsule passes into the intestines.\n\n
\nA tablet covered with a substance that is designed to delay the release of\nactive and/or inert ingredient(s) until the tablet passes into the intestines.\n\n
\nA solid, semi-solid, solution or suspension in which active and/or inert\ningredient(s) release is controlled by the erosion rate of a carrier matrix,\nwhich is designed to release ingredients at a controlled, prolonged rate so as\nto reduce dosing frequency.\n\n
\nA solid, semi-solid, solution or suspension designed to release active and/or\ninert ingredient(s) at a controlled, prolonged rate so as to reduce dosing\nfrequency.\n\n
\nCode indicating that additional follow through by the pharmacist is required\n\n
\nA solid in the shape of a small sphere intended to be embedded securely in the\nbody and designed to release active and/or inert ingredient(s) at a controlled,\nprolonged rate so as to reduce dosing frequency.\n\n
\nA capsule designed to release active and/or inert ingredient(s) at a controlled,\nprolonged rate so as to reduce dosing frequency.\n\n
\nA capsule covered with a thin layer of substance and is designed to release\nactive and/or inert ingredient(s) at a controlled, prolonged rate so as to\nreduce dosing frequency.\n\n
\nA pellet covered with a thin layer of substance that is designed to release\nactive and/or inert ingredient(s) at a controlled, prolonged rate so as to\nreduce dosing frequency.\n\n
\nA solid or liquid core composed of active and/or inert ingredient(s) enclosed by\na polymer coated shell. It is designed to release active and/or inert\ningredient(s) at a controlled, prolonged rate so as to reduce dosing frequency.\n\n
\nAn extended release capsule covered with a substance that is designed to delay\nthe release of active and/or inert ingredient(s) until the capsule passes into\nthe intestines.\n\n
\nA extended release tablet covered with a substance that is designed to delay the\nrelease of active and/or inert ingredient(s) until the tablet passes into the\nintestines.\n\n
\nA solid in the shape of a slender, elongated thread that is designed to release\nactive and/or inert ingredient(s) at a controlled, prolonged rate so as to\nreduce dosing frequency.\n\n
\nA film that is designed to release active and/or inert ingredient(s) at a\ncontrolled, prolonged rate so as to reduce dosing frequency.\n\n
\nA capsule covered with a thin layer of water soluble or insoluble polymer and is\ndesigned to release active and/or inert ingredient(s) at a controlled, prolonged\nrate so as to reduce dosing frequency.\n\n
\nIndicates that an adverse immune event may occur due to the patient's previously\ndemonstrated heightened allergic response to the drug product in question.\n\n
\nPt has a listed allergy to medication/component of medication prescribed\n[DRUG_NAME]. Please advise: To fill as is, send denial to this request with\nnote stating reason fill is acceptable. If med should not be filled, Cancel Rx\nand send replacement.\n\n
\nCode indicating the referral of a patient to another health care provider\nfollowing evaluation by the pharmacist.\n\n
\nA substance that forms a suspension upon reconstitution and designed to release\nactive and/or inert ingredient(s) at a controlled, prolonged rate so as to\nreduce dosing frequency.\n\n
\nA solution that becomes gelatinous upon administration and is designed to\nrelease active and/or inert ingredient(s) at a controlled, prolonged rate so as\nto reduce dosing frequency.\n\n
\nA solid in the shape of a small particle or grain designed to release active\nand/or inert ingredient(s) at a controlled, prolonged rate so as to reduce\ndosing frequency.\n\n
\nA granule intended for administration as a suspension and designed to release\nactive and/or inert ingredient(s) at a controlled, prolonged rate so as to\nreduce dosing frequency.\n\n
\nAn insert designed to release active and/or inert ingredient(s) at a controlled,\nprolonged rate so as to reduce dosing frequency.\n\n
\nA solution or suspension that is designed to release active and/or inert\ningredient(s) at a controlled, prolonged rate so as to reduce dosing frequency.\n\n
\nA patch designed to release active and/or inert ingredient(s) at a controlled,\nprolonged rate so as to reduce dosing frequency.\n\n
\nA suppository that is designed to release active and/or inert ingredient(s) at a\ncontrolled, prolonged rate so as to reduce dosing frequency.\n\n
\nA suspension that is designed to release active and/or inert ingredient(s) at a\ncontrolled, prolonged rate so as to reduce dosing frequency.\n\n
\nA tablet designed to release active and/or inert ingredient(s) at a controlled,\nprolonged rate so as to reduce dosing frequency.\n\n
\nIndicator used to convey that the patient affirmed understanding of the\ninstructions provided by the pharmacist regarding the use and handling of the\nmedication dispensed.\n\n
\nA distillate composed of active and/or inert ingredient(s) extracted from plant\nor animal matter, and represented in concentrated form.\n\n
\nA thin layer of water soluble or insoluble polymer intended to coat the site of\nadministration.\n\n
\nA tablet covered with a thin layer of water soluble or insoluble polymer and is\ndesigned to release active and/or inert ingredient(s) at a controlled, prolonged\nrate so as to reduce dosing frequency.\n\n
\nA tablet covered with a thin layer of water soluble or insoluble polymer.\n\n
\nA solid composed of active and/or inert ingredient(s) that resembles small, thin\nchips.\n\n
\nA solution or suspension distillate composed of active and/or inert\ningredient(s) extracted from plant or animal matter and alcohol as the solvent\nand/or preservative. Fluid extract is prepared by percolation and subsequent\nevaporation such that the ingredient in each milliliter of the fluid extract is\nequivalent to 1 gram of the dried plant or animal derived matter.\n\n
\nAn aerated solution or suspension.\n\n
\nA solution or suspension that produces dense bubbles when combined with water.\n\n
\nA substance intended for administration as a solution.\n\n
\nA substance intended for administration as a suspension.\n\n
\nCognitive service whereby the pharmacist supplies a product that assists the\npatient in complying with instructions for taking medications.\n\n
\nA solution that is reconstituted from a frozen pre-mixed form intended for\nintravenous administration simultaneously with an established compatible\nmaintenance infusion drug by a mutual intravenous access.\n\n
\nA solution or suspension taken orally and moved around the back of the throat by\ntilting the head back and forcing air from the lungs through the solution.\nUnless specifically directed, the solution is expelled and not swallowed.\n\n
\nAn elastic aeriform fluid in which the molecules are separated from one another\nand have freedom of movement.\n\n
\nA semi-solid composed of a solid, three dimensional, cross linked matrix of\npolymers within a liquid, yielding a jelly-like material unable to flow at\nsteady state.\n\n
\nA solution intended for administration in a drop-wise fashion; it becomes\ngelatinous upon administration.\n\n
\nA solution that becomes a gelatinous liquid after administration.\n\n
\nA capsule covered with a thin layer of gelatin.\n\n
\nA tablet covered with a layer of gelatin.\n\n
\nAn apparatus that converts solutions, suspensions or solids, composed of active\nand/or inert ingredient(s) into a vapor or gas by heat or chemical reaction.\n\n
\nA solid composed of sucrose, lactose or other polysaccharides formed into small\nglobular pellets impregnated with active and/or inert ingredient(s).\n\n
\nCognitive service whereby the pharmacist performs a patient care activity by\npersonally administering the medication.\n\n
\nA solid composed of a piece of skin or other tissue intended for implantation\ninto or on the body.\n\n
\nA solid composed of small particles or grains.\n\n
\nA solid in the shape of a small particle or grain mixed with a liquid to form a\nsolution or suspension before administration.\n\n
\nA granule intended for administration as a solution.\n\n
\nA granule intended for administration as a suspension.\n\n
\nA semi-solid composed of a sticky, mucilaginous polysaccharide.\n\n
\nA capsule covered with a rigid outer shell.\n\n
\nA solid composed of sucrose, lactose, or other polysaccharides formed into small\nglobular pellets of uniform size which can be classified as homeopathic.\n\n
\nA tablet dissolved in solvent and intended for administration by hypodermic\ninjection.\n\n
\nA solid, semi-solid, solution or suspension that is designed to release its\nactive and/or inert ingredient(s) upon administration with no enhanced, delayed\nor extended release effect.\n\n
\nPhysician is prescribing this medication with knowledge of the potential\nconflict.\n\n
\nA solid intended for insertion securely within the body.\n\n
\nA pellet intended for insertion securely within the body.\n\n
\nVaporized active and/or inert ingredient(s) intended for administration by\ninhalation.\n\n
\nPowdered medication inhaled as a measured dose.\n\n
\nLiquid medication intended to be inhaled.\n\n
\nA capsule composed of powders intended for oral inhalation. This dose form may\nalso refer to capsules that are intended for use in inhalers.\n\n
\nA substance intended for injection.\n\n
\nA suspension intended for injection that is designed to release active and/or\ninert ingredient(s) at a controlled, prolonged rate so as to reduce dosing\nfrequency.\n\n
\nA substance composed of complexed active and/or inert ingredient(s) with natural\nor synthetic lipids that is intended for injection.\n\n
\nA suspension composed of active and/or inert ingredient(s) encapsulated in\nliposomes and intended for injection.\n\n
\nA freeze dried powder intended for injection following reconstitution with a\nsuitable solvent.\n\n
\nA solution intended for injection.\n\n
\nA suspension intended for injection and is sonicated while a gas is bubbled\nthrough the suspension resulting in the creation of microspheres by the solid\nparticles.\n\n
\nA suspension intended for injection.\n\n
\nA solid or semi-solid intended for administration within the body.\n\n
\nA powder intended for use within the body.\n\n
\nA solution intended for administration into the intraperitoneal cavity.\n\n
\nA solid intended for placement within the uterine cavity where active and/or\ninert ingredient(s) are released from an apparatus at a controlled rate.\n\n
\nA solution intended for intravenous administration simultaneously with an\nestablished compatible maintenance infusion drug by a mutual intravenous access.\n\n
\nA solution composed of a homogenous liquid that contains active and/or inert\ningredient(s) dissolved in a suitable solvent or mixture of mutually miscible\nsolvents.\n\n
\nCode indicating that an initial evaluation of a patient or complaint/symptom for\nthe purpose of developing a therapeutic plan.\n\n
\nA solution or suspension used to bathe or flush open wounds or body cavities.\n\n
\nA semi-solid composed of suspensions of active and/or inert ingredient(s) in any\ntype of highly viscous material, including gelatin or gel. The structural matrix\nof the jelly contains high levels of liquid.\n\n
\nA collection of unrelated materials that are used together to orchestrate dosage\nadministration.\n\n
\nA semi-solid with viscosity similar to that of a lotion, which is intended for\ntopical use and must be rubbed into the site of administration to release the\nactive and/or inert ingredient(s).\n\n
\nA substance composed of active and/or inert ingredient(s) encapsulated in\nliposomes and intended for injection.\n\n
\nA solid or semi-solid with a waxy consistency in the shape of a stick and\nintended for use on the lips.\n\n
\nA substance in the fluid state of matter having no fixed shape but a fixed\nvolume.\n\n
\nA capsule composed of liquid covered with an outer shell, which is usually\nprepared from gelatin.\n\n
\nA solution or suspension composed of an anionic surfactant used for cleansing.\n\n
\nA solid composed of a sugared, medicated candy mounted to a stick, which can be\nheld while sucking or chewing on the candy.\n\n
\nCase management activities of a pharmacist related to the care being delivered by\nmultiple providers.\n\n
\nA semi-solid composed of an oil in water emulsion, with lower viscosity than\ncream or gel.\n\n
\nA lotion composed of anionic surfactant intended for administration to the hair\nor scalp.\n\n
\nA solid composed of active and/or inert ingredient(s), sweeteners, other\nflavorings and mucilage, intended for oral administration.\n\n
\nA freeze dried powder intended for injection following reconstitution with a\nsuitable solvent to form a suspension that is designed to release active and/or\ninert ingredient(s) at a controlled, prolonged rate so as to reduce dosing\nfrequency.\n\n
\nA freeze dried powder composed of active and/or inert ingredient(s) encapsulated\nin liposomes and intended for injection following reconstitution with a suitable\nsolvent to form a suspension.\n\n
\nA freeze dried powder intended for injection following reconstitution with a\nsuitable solvent to form a solution.\n\n
\nA freeze dried powder intended for injection following reconstitution with a\nsuitable solvent to form a suspension.\n\n
\nA solid composed of an impermeable occlusive backing, a formulation matrix in\nwhich the active and/or inert ingredient(s) are dissolved or dispersed and an\nadhesive layer. It is intended for external application.\n\n
\nA solid in the shape of a bar composed of active and inert ingredient(s) in an\nanionic surfactant, for cleansing.\n\n
\nA film composed of active and/or inert ingredient(s).\n\n
\nCognitive service whereby the pharmacist reviews and evaluates the\nappropriateness of a prescribed medication's dose, interval, frequency and/or\nformulation.\n\n
\nA liquid composed of active and inert ingredient(s) in an anionic surfactant,\nfor cleansing.\n\n
\nA solid composed of active and/or inert ingredient(s) in a soft, non-adhesive\nand absorbent piece of fabric or other material.\n\n
\nA solution or suspension composed of active and inert ingredient(s) in an\nanionic surfactant and intended for administration to the hair and/or scalp.\n\n
\nA substance composed of active and/or inert ingredient(s) in an anionic\nsurfactant, for cleansing.\n\n
\nA solid composed of a porous, interlacing, absorbent, usually shape retaining\nmaterial that contains active and/or inert ingredient(s).\n\n
\nA solid composed of active and/or inert ingredient(s) on a small piece of\nabsorbent material attached to one end of a stick.\n\n
\nA fabric or a narrow extruded synthetic material usually with an adhesive on one\nor both sides, impregnated with active and inert ingredient(s).\n\n
\nA capsule covered with a semipermeable film.\n\n
\nA tablet covered with a semipermeable film.\n\n
\nAn aerosol contained in a device with valves that permits the release of a\nspecified quantity of active and/or inert ingredient(s) upon activation.\n\n
\nCode indicating that dosage has been evaluated with respect to risk for the\npatient.\n\n
\nA liquid medication delivered as a mist to be inhaled as a measured dose\n\n
\nA gel contained in a device with valves that permits the release of a uniform\ndose of gel that composed of active and/or inert ingredient(s) upon activation.\n\n
\nA powder contained in a device with valves that permits the dispensing of active\nand/or inert ingredient(s) upon activation.\n\n
\nA spray contained in a device with valves that permits the dispensing of a\nspecified quantity of active and/or inert ingredient(s) upon activation.\n\n
\nA solution or suspension present in a small volume or mass, intended for\nadministration to the rectum.\n\n
\nA solid, semi-solid, solution or suspension exhibiting an altered inherent rate\nof release of active and/or inert ingredient(s).\n\n
\nA solution or suspension intended for oral administration, for its deodorizing\nor antiseptic effects in the oral cavity. Usually, the mouthwash is swished\naround the mouth and expelled.\n\n
\nA spray intended for administration to the mucosa.\n\n
\nA solution intended for administration to the surface of the mucosa membranes.\n\n
\nA tablet composed of active and/or inert ingredient(s) that have been compressed\ninto multiple layers and is designed to release active and/or inert\ningredient(s) at a controlled, prolonged rate so as to reduce dosing frequency.\n\n
\nIndicates that the use of the drug may be inappropriate in light of a specific\nmedical condition that the patient has. The existence of the specific medical\ncondition is inferred from drugs in the patient's medication history.\n\n
\nCode indicating that activities including interventions with prescribers and\npatients related to the enforcement of a pharmacy benefit plan formulary have\noccurred. Comment: Use this code for cross-licensed brand products or generic to\nbrand interchange.\n\n
\nA tablet composed of active and/or inert ingredient(s) that have been compressed\nto form a tablet that contains multiple layers.\n\n
\nA substance intended for administration in the nares.\n\n
\nA cream intended for administration to the mucosa of the nose.\n\n
\nA gel intended for administration to the mucosa of the nose.\n\n
\nAn inhalant intended for administration through the nose.\n\n
\nA medication delivered as a mist to be inhaled through the nose as a measured\ndose\n\n
\nAn ointment intended for administration to the mucosa of the nose.\n\n
\nA solution intended for administration to the mucosa of the nose.\n\n
\nA spray intended for administration to the mucosa of the nose.\n\n
\nA suspension intended for administration to the mucosa of the nose.\n\n
\nThe selection of a chemically and therapeutically identical product to that\nspecified by the prescriber for the purpose of achieving cost savings for the\npayer.\n\n
\nA spray composed of active and/or inert ingredient(s) that are expelled from a\ndelivery device without the use of a propellant.\n\n
\nA solid composed of a small piece of absorbent material that does not contain\nactive ingredient(s), attached to one end of a small stick.\n\n
\nAn indication that the dosage form is not relevant or appropriate.\n\n
\nA system that is placed in the eye, usually under the lower eyelid, from which\nthe active and/or inert ingredient(s) diffuses through a membrane at a\ncontrolled rate.\n\n
\nA solution or suspension that is hydrophobic, soluble in organic solvents, and\nliquid at ambient temperature.\n\n
\nA semi-solid, viscous in texture, that may be composed of a variety of bases\nincluding hydrocarbons, emulsifiers or vegetable oils, and mixed with active\nand/or inert ingredient(s).\n\n
\nA substance intended for administration in or around the eye.\n\n
\nA cream intended for administration in or around the eye.\n\n
\nA gel intended for administration in or around the eye.\n\n
\nA solution intended for irrigation of the eye.\n\n
\nCode indicating an action of supplying a medication to a patient through any of\nseveral routes-oral, topical, intravenous, intramuscular, intranasal, etc.\n\n
\nA solution or suspension intended for administration in the eye.\n\n
\nA ointment intended for administration in or around the eye.\n\n
\nA solution intended for administration in or around the eye.\n\n
\nA suspension intended for administration in or around the eye.\n\n
\nA substance intended for administration through the mouth.\n\n
\nA capsule intended for administration through the mouth.\n\n
\nA cream intended for administration through the mouth.\n\n
\nA foam intended for administration through the mouth.\n\n
\nA gel intended for administration through the mouth.\n\n
\nAn ointment intended for administration through the mouth.\n\n
\nBenefits of the prescribed medication outweigh the risks.\n\n
\nA paste intended for administration through the mouth.\n\n
\nA powder intended for administration through the mouth.\n\n
\nA suspension composed of active and/or inert ingredient(s) that requires\nreconstitution and is intended oral administration.\n\n
\nA solution intended for oral administration.\n\n
\nA spray intended for administration into the mouth.\n\n
\nA strip intended for administration through the mouth.\n\n
\nA suspension intended for oral administration.\n\n
\nA suspension composed of a suspension that has been prepared immediately prior\nto dispensing or oral administration.\n\n
\nA tablet intended for oral administration.\n\n
\nA tablet that disintegrates rapidly, usually within a matter of seconds, when\nplaced upon the tongue but is also designed to impede the immediate release of\nthe active and/or inert ingredient(s) after administration.\n\n
\nPrescriber is aware of the risk and will be monitoring the patient.\n\n
\nA tablet which disintegrates and dissolves quickly (usually within a matter of\nseconds) in the mouth. Additional water to complete dissolution is not\nnecessary.\n\n
\nA tablet with a semi-permeable membrane composed of active and/or inert\ningredient(s) and an osmotic agent with a laser drilled central core. Upon\ningestion, water permeates the core and the ingredient is dissolved and\nreleased.\n\n
\nA solid designed to release active and/or inert ingredient(s) at a controlled,\nprolonged rate so as to reduce dosing frequency, based on osmotic pressure\nbetween the inside of the dosage form and the external environment.\n\n
\nA substance intended for administration either on the outer ear or into the\nauditory canal.\n\n
\nA cream intended for administration either on the outer ear or into the auditory\ncanal.\n\n
\nAn ointment intended for administration either on the outer ear or into the\nauditory canal.\n\n
\nA solution intended for administration either on the outer ear or into the\nauditory canal.\n\n
\nA suspension intended for administration either on the outer ear or into the\nauditory canal.\n\n
\nA number of individual items packaged as a unit.\n\n
\nA solid composed of a material that contains active and/or inert ingredient(s)\nwhich is intended to be placed in a cavity or depression within the body.\n\n
\nCode indicating prescriber communication related to collection of information or\nclarification of a specific limited problem.\n\n
\nA solid composed of a soft, non-adhesive and absorbent piece of fabric or other\nmaterial.\n\n
\nA substance intended for administration by injection.\n\n
\nA semi-solid composed of a large proportion of solids and finely dispersed\nactive and/or inert ingredient(s) in a fat-based vehicle.\n\n
\nA solid or semi-solid composed of a lozenge, that contains active and/or inert\ningredient(s) that dissolves when sucked in the mouth.\n\n
\nA solid composed of an impermeable occlusive backing and a formulation matrix in\nwhich the active and/or inert ingredient(s) are dissolved or dispersed; possibly\nincludes an adhesive layer.\n\n
\nA solution or suspension intended for use in children.\n\n
\nA suppository intended for administration to children.\n\n
\nA solid composed of a small granular or compressed mass that contains highly\npurified active and/or inert ingredient(s).\n\n
\nThe form in which active and/or inert ingredient(s) are physically presented.\n\n
\nA solid composed of a small, round object composed of active and/or inert\ningredient(s).\n\n
\nCode indicating comprehensive review and evaluation of a patient's entire\nmedication regimen.\n\n
\nA semi-solid composed of a soft, smooth mass with relatively thick consistency\nand strong adhesiveness that becomes solid when dry.\n\n
\nPolymeric microspheres composed of biocompatible polymer that contains active\nand/or inert ingredient(s) designed for release at a controlled rate.\n\n
\nA semi-solid composed of a soft, moist mass that is made by wetting an absorbent\nsolid substance.\n\n
\nA solid composed of a mixture of dry, finely divided active and/or inert\ningredient(s).\n\n
\nA powder composed of active and/or inert ingredient(s) and packaged under\npressure. Ingredients are released upon activation of an appropriate valve\nsystem.\n\n
\nA powder intended for injection following reconstitution to form a suspension\nthat is designed to release active and/or inert ingredient(s) at a controlled,\nprolonged rate so as to reduce dosing frequency.\n\n
\nA powder intended for injection following reconstitution to form a solution.\n\n
\nA powder intended for injection following reconstitution to form a suspension.\n\n
\nA powder intended for injection following reconstitution to form a solution or\nsuspension.\n\n
\nA powder that yields a solution intended for oral administration following\nreconstitution.\n\n
\nPatient has taken medication previously without issue.\n\n
\nA powder that yields a suspension intended for oral administration following\nreconstitution.\n\n
\nA powder mixed with a liquid to form a solution or suspension before\nadministration.\n\n
\nA powder that yields a solution following reconstitution with an appropriate\nliquid.\n\n
\nA powder that forms a suspension when reconstituted with a liquid solution.\n\n
\nPowder intended for oral inhalation.\n\n
\nA granule composed of a mixture of small (powder like), dry particles or grains,\nwhich does not have the ability to release gas upon contact with water.\n\n
\nActive and/or inert ingredients in an applicator delivered as a single measured\ndose.\n\n
\nA syringe that lacks a conventional plunger, resembles a writing pen, and is\ndesigned to dispense a pre-loaded dose of a drug. It may be designed to deliver\na single dose or be designed for repeated use.\n\n
\nA solution or suspension intended to be injected in a syringe, cartridge or pen.\n\n
\nA semi-solid, having a relatively thick consistency, intended for oral\nadministration to facilitate ease of swallowing.\n\n
\nCode indicating verbal and/or written communication by a pharmacist to enhance\nthe patient's knowledge about the condition under treatment or to develop skills\nand competencies related to its management.\n\n
\nA substance that requires reconstitution with a suitable solvent and is intended\nfor oral administration in a drop-wise fashion.\n\n
\nA solution that requires reconstitution with a suitable solvent, and is intended\nfor oral administration.\n\n
\nA substance intended for administration in or around the rectum.\n\n
\nA cream intended for administration in or around the rectum.\n\n
\nA foam intended for administration to the rectum.\n\n
\nA gel intended for administration to the rectum.\n\n
\nAn ointment intended for administration in or around the rectum.\n\n
\nA powder intended for administration to the rectum.\n\n
\nA spray intended for administration to the rectum.\n\n
\nA suppository intended for administration within the rectum.\n\n
\nCode indicating the establishment of a medication history database on a patient\nto serve as the foundation for the ongoing maintenance of a medication profile.\n\n
\nA semi-solid composed of a mixture of gum and a plant based hydrocarbon.\n\n
\nA solid composed active and/or inert ingredient(s) of in the shape of a hoop.\n\n
\nA solution or suspension intended for irrigation purposes.\n\n
\nA semi-solid composed of a thick, fat or wax-based ointment or cerate with a\nconsistency somewhere between an ointment and a plaster.\n\n
\nA substance with properties of both a solid and a liquid in terms of viscosity\nand rigidity. Semi-solids include, but are not limited to, ointments, creams,\npastes and gels.\n\n
\nA solution or suspension composed of an anionic surfactant and intended for\nadministration to the hair and/or scalp.\n\n
\nA suspension composed of anionic surfactant and intended for administration to\nthe hair and/or scalp.\n\n
\nA patch intended for administration to the skin.\n\n
\nAn anionic surfactant for cleansing.\n\n
\nA capsule composed of active and/or inert ingredient(s) covered with a soft\nouter shell, which is usually prepared from gelatin.\n\n